For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for C-reactive protein (CRP).
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
For the quantitative determination of human C-reactive protein (CRP) in serum an
For the quantitative determination of human C-reactive protein (CRP) in serum and plasma by immunoturbidimetric assay.
DCK
C-Reactive Protein, Antigen, Antiserum, And Control
For the quantitative determination of human rheumatoid factor (RF) in serum by i
For the quantitative determination of human rheumatoid factor (RF) in serum by immunoturbidimetric assay.
For the quantitative determination of human albumin in urine by immunoturbidimet
For the quantitative determination of human albumin in urine by immunoturbidimetric assay.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for microalbumin.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for microalbumin.
For the quantitative determination of human cystatin C in serum, EDTA plasma, or
For the quantitative determination of human cystatin C in serum, EDTA plasma, or lithium heparin plasma by immunoturbidimetric assay.
For the quantitative determination of human ferritin in serum and plasma by immu
For the quantitative determination of human ferritin in serum and plasma by immunoturbidimetric assay.
For the quantitative determination of human 3rd complement component (Complement
For the quantitative determination of human 3rd complement component (Complement C3) in serum by immunoturbidimetric assay.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for C-reactive protein (CRP).
DCK
C-Reactive Protein, Antigen, Antiserum, And Control
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for hemoglobin A1c.
For the calibration of the K-ASSAY® Alpha-1 AG, Alpha-1 AT, Complement C3, Comle
For the calibration of the K-ASSAY® Alpha-1 AG, Alpha-1 AT, Complement C3, Comlement C4, Haptoglobin, IgA, IgG, IgM, and Transferrin assays.
For the quantitative determination of human streptolysin O (ASO) in serum by imm
For the quantitative determination of human streptolysin O (ASO) in serum by immunoturbidimetric assay.
For the quantitative determination of human apolipoprotein B (Apo B) in serum by
For the quantitative determination of human apolipoprotein B (Apo B) in serum by immunoturbidimetric assay.
For the quantitative determination of human alpha-1 anti-trypsin (Alpha-1 AT) in
For the quantitative determination of human alpha-1 anti-trypsin (Alpha-1 AT) in serum by immunoturbidimetric assay.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for Apolipoprotein AI and B.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for Apolipoprotein AI and B.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for beta-2 microglobulin.
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for beta-2 microglobulin.
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for D-Dimer.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
For the quantitative determination of human total IgE in serum or plasma by immu
For the quantitative determination of human total IgE in serum or plasma by immunoturbidimetric assay.
For the quantitative determination of human D-dimer in plasma or serum by immuno
For the quantitative determination of human D-dimer in plasma or serum by immunoturbidimetric assay.
For the quantitative determination of human insulin in serum and plasma by immun
For the quantitative determination of human insulin in serum and plasma by immunoturbidimetric assay.
For the quantitative determination of human C-reactive protein (CRP) in serum by
For the quantitative determination of human C-reactive protein (CRP) in serum by immunoturbidimetric assay.
DCK
C-Reactive Protein, Antigen, Antiserum, And Control
For the quantitative determination of human 4th complement component (Complement
For the quantitative determination of human 4th complement component (Complement C4) in serum by immunoturbidimetric assay.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for beta-2 microglobulin.
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
1
K-ASSAY® Beta-2 Microglobulin / Ferritin - Serum / Plasma Control
Control plasma for assays aimed to determine the functional phenotype for activa
Control plasma for assays aimed to determine the functional phenotype for activated protein C resistance caused by the Factor V Leiden mutation (FV:Q506).
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.
ROTROL P is a quality control material for monitoring accuracy and precision of
ROTROL P is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only.
ROTROL N is a quality control material for monitoring accuracy and precision of
ROTROL N is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only.
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve – clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The star-tem® reagent is intended for use as recalcification reagent in the NATEM and INTEM assay on the ROTEM® delta. The corresponding assays are described in the NATEM assay application sheet and in the Instructions for Use of the in-tem® reagent (REF 503-02-US), resp.
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The hep-tem® assay is a semi-quantitative in vitro diagnostic assay used to inactivate heparin in patients receiving unfractionated heparin on the ROTEM® delta. To monitor the coagulation process citrated whole blood specimens are used. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)).
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The in-tem® assay is a semi-quantitative in vitro diagnostic assay used to monitor the coagulation process via the intrinsic pathway in citrated whole blood specimens on the ROTEM® delta. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)).
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.